Sanofi only moved into its Genzyme headquarters in 2018, so when it inked a new—and massive—lease in nearby Cambridge Crossing last year, the company found itself in prime position to make another real estate deal.
Sanofi only moved into its Genzyme headquarters in 2018, so when it inked a new—and massive—lease in nearby Cambridge Crossing last year, the company found itself in prime position to make another real estate deal.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
